allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant
RxNorm concept 2626464, clinical drug (scd). Prescribable name: allogeneic processed thymus tissue-agdc 22,000 mm2 Implant.
- RxCUI
- 2626464
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2626464 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
allogeneic processed thymus tissue-agdc 22,000 mm2 Implant
Related concepts
- allogeneic processed thymus tissue-agdc 220 SQCM (SCDC, consists of)
- Drug Implant (DF, has dose form)
- allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant [Rethymic] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2626464 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2626464 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2626464. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.